Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509340 · ClinicalTrials.gov registry record · Phase 1
Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
A Phase 1 study, sponsored by RAND.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00509340: Clinical Trial Phase 1 study, sponsored by RAND.
NCT00509340 is a Phase 1 study that was terminated before completion, run by RAND. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00509340, a Phase 1 study, was terminated before completion, sponsored by RAND.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of a cognitive behavioral intervention versus usual clinic care in helping HIV infected adults with depression to take their HIV medications on schedule.
Interventions
- BEHAVIORAL Cognitive behavioral therapy (CBT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Why NCT00509340 stopped before completion
NCT00509340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Cognitive behavioral therapy (CBT) is the first listed.
NCT00509340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00509340 about?
NCT00509340 is a clinical study titled "Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy". This study will compare the effectiveness of a cognitive behavioral intervention versus usual clinic care in helping HIV infected adults with depression to take their HIV medications on schedule.
What is the current status of trial NCT00509340?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2007-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00509340?
The interventions under investigation include: Cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00509340?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00509340's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia